Frequently Asked Questions
The market is segmented based on North America Clinical Chemistry Analyser Market, By Product (Analysers, Reagents, Calibrators, Controls, Standards, Others), Analyser Technology (Semi- Automated Clinical Chemistry Analysers, Fully Automated Clinical Chemistry Analysers), Test Analysis (Basic Metabolic Panel (BMP), Liver Panel, Electrolyte Panel, Renal Profile, Lipid Profile, Specialty Chemical Tests, Thyroid Function Panel), End User Analysis (Hospitals, Academic Research Centres, Diagnostic Laboratories, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2030.
.
The North America Clinical Chemistry Analyzer Market size was valued at USD 6.96 USD Billion in 2022.
The North America Clinical Chemistry Analyzer Market is projected to grow at a CAGR of 4.51% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffman-La Roche , Danaher Corporation, Abbott, Thermo Fisher Scientific , Siemens AG, HORIBA Ltd, Sysmex Corporation, HITACHI, EKF Diagnostics Holdings plc, Ortho Clinical Diagnostics, ELITECH Group, Mindray Medical International Limited, BIOBASE Group, SFRI Medical Diagnostics, Trivitron Healthcare Pvt , Randox Laboratories
.
The market report covers data from the U.S., Canada and Mexico.
